CClinicalTrials.gg
CompletedNCT04064047Updated Jan 13, 2020

Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided Biopsy

An interventional study of Trans rectal ultrasound guided prostate biopsy and Trans rectal ultrasound in Pain, Prostate Cancer and Rectal/Anal, sponsored by Assaf-Harofeh Medical Center. Completed. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-01-13.

Sponsored by Assaf-Harofeh Medical Center · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Dec 2016, registered Jan 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
284
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

Transrectal ultrasound guided prostate biopsy is performed with a periprostatic nerve block to the neurovascular bundle bilaterally. This does not reduce the pain due to probe insertion and manipulation prior to nerve blockage.

Our study goal is to assess whether topical analgesia would reduce pain during the early stages of the procedure.

Read the detailed description

Prospective, randomized controlled study. Patients signed an informed consent form. Exclusion criteria were Lidocaine allergy or pre-planned general anesthesia.

Patients were randomized into 6 groups: (1) nerve block with 5 ml 1% lidocaine for each neurovascular bundle + perianal topical application of 10 ml 5% lidocaine cream; (2) as in (1) plus application of 10 ml 5% lidocaine cream evenly on rectal walls. For each approach exposure times of 5, 10 and 20 minutes were allowed, all together 6 groups plus a control group of patients who received periprostatic nerve block only. A 0-10 Visual analogue scale (VAS) was filled by the patients at 5 time points: immediately after probe insertion, during probe manipulation and prostate assessment, immediately following neurovascular bundle nerve blockage, after prostate biopsies and a global pain estimation of the procedure.

02

Conditions studied

  • Pain
  • Prostate Cancer
  • Rectal/Anal

Browse trials for

03

In context

Prostatic Neoplasms

6,370 studies on the registry are indexed under Prostatic Neoplasms; 1,400 are open to participants now.

This study's enrollment of 284 is above the median of 58 across 4,822 interventional studies indexed under Prostatic Neoplasms.

Browse Prostatic Neoplasms studies →

Lead sponsor

Assaf-Harofeh Medical Center is the lead sponsor of 258 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Males referred to TRUSGBx due to elevated prostate specific antigen (PSA)
  • Abnormal findings on digital rectal examination (DRE)
  • Repeat biopsies as part of Active Surveillance (AS)
  • Continuously elevated PSA levels despite prior negative for malignancy biopsies
  • Previous histological findings of significant HGPIN were enrolled

Exclusion criteria

Exclusion Criteria:

  • Known sensitivity to Lidocaine
  • Pre-planned biopsy under general anesthesia
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
284 participants (actual)

Study arms

  • Active comparator
    External Anal application - 5 minutes exposure

    Anal application of lidocaine cream 5% for 5 minutes before probe insertion. After probe insertion and prior to biopsy, a periprostatic nerve block was performed with 10 mL of 1% Lidocaine (5 mL on each side).

    Procedure: Trans rectal ultrasound guided prostate biopsy · Procedure: Trans rectal ultrasound · Procedure: Prostate biopsy · Procedure: Periprostatic nerve block

  • Active comparator
    External Anal application - 10 minutes exposure

    Anal application of lidocaine cream 5% for 10 minutes before probe insertion. After probe insertion and prior to biopsy, a periprostatic nerve block was performed with 10 mL of 1% Lidocaine (5 mL on each side).

    Procedure: Trans rectal ultrasound guided prostate biopsy · Procedure: Trans rectal ultrasound · Procedure: Prostate biopsy · Procedure: Periprostatic nerve block

  • Active comparator
    External Anal application - 20 minutes exposure

    Anal application of lidocaine cream 5% for 20 minutes before probe insertion. After probe insertion and prior to biopsy, a periprostatic nerve block was performed with 10 mL of 1% Lidocaine (5 mL on each side).

    Procedure: Trans rectal ultrasound guided prostate biopsy · Procedure: Trans rectal ultrasound · Procedure: Prostate biopsy · Procedure: Periprostatic nerve block

  • Active comparator
    External Anal plus intrarectal - 5 minutes exposure

    Anal application plus intrarectal application of 5% lidocaine cream for 5 minutes before probe insertion. After probe insertion and prior to biopsy, a periprostatic nerve block was performed with 10 mL of 1% Lidocaine (5 mL on each side).

    Procedure: Trans rectal ultrasound guided prostate biopsy · Procedure: Trans rectal ultrasound · Procedure: Prostate biopsy · Procedure: Periprostatic nerve block

  • Active comparator
    External Anal plus intrarectal - 10 minutes exposure

    Anal application plus intrarectal application of 5% lidocaine cream for 10 minutes before probe insertion. After probe insertion and prior to biopsy, a periprostatic nerve block was performed with 10 mL of 1% Lidocaine (5 mL on each side).

    Procedure: Trans rectal ultrasound guided prostate biopsy · Procedure: Trans rectal ultrasound · Procedure: Prostate biopsy · Procedure: Periprostatic nerve block

  • Active comparator
    External Anal plus intrarectal - 20 minutes exposure

    Anal application plus intrarectal application of 5% lidocaine cream for 20 minutes before probe insertion. After probe insertion and prior to biopsy, a periprostatic nerve block was performed with 10 mL of 1% Lidocaine (5 mL on each side).

    Procedure: Trans rectal ultrasound guided prostate biopsy · Procedure: Trans rectal ultrasound · Procedure: Prostate biopsy · Procedure: Periprostatic nerve block

  • Sham comparator
    Control group

    No anal application of lidocaine cream prior to probe insertion. After probe insertion and prior to biopsy, a periprostatic nerve block was performed with 10 mL of 1% Lidocaine (5 mL on each side).

    Procedure: Trans rectal ultrasound guided prostate biopsy · Procedure: Trans rectal ultrasound · Procedure: Prostate biopsy · Procedure: Periprostatic nerve block

Interventions

  • ProcedureTrans rectal ultrasound guided prostate biopsy

    The investigators checked visual analogue scale of pain at different time periods: prior to probe insertion, during probe insertion. during probe manipulation in the rectum, during performance of periprostatic nerve block, during actual biopsy collection and at termination of procedure.

  • ProcedureTrans rectal ultrasound

    Performing a prostate biopsy using a transrectal ultrasound probe - the BK pro focus 2202 transrectal ultrasound and the 8808 bi-plane transrectal probe

    Also known as: BK pro focus 2202 transrectal ultrasound and the 8808 bi-plane transrectal probe

  • ProcedureProstate biopsy

    Prostate biopsy guided by a transrectal ultrasound with an 18 gauge needle

  • ProcedurePeriprostatic nerve block

    Performing a bilateral peri-prostatic nerve block with 10 mL of 1% lidocaine (5 mL on each side)

06

What researchers measure

Primary outcomes

  1. Pain level before probe insertion

    Self reported by the patient using a 0-10 visual analogue scale. 0 being no pain at all, 10 being worst pain imaginable.

    Time frame: Before transrectal ultrasound probe insertion

  2. Pain level at TRUS probe insertion

    Self reported by the patient using a 0-10 visual analogue scale. 0 being no pain at all, 10 being worst pain imaginable.

    Time frame: During transrectal ultrasound probe insertion into the rectum (defined as beginning of procedure)

  3. Pain level during TRUS probe manipulation in the rectum

    Self reported by the patient using a 0-10 visual analogue scale. 0 being no pain at all, 10 being worst pain imaginable.

    Time frame: During transrectal ultrasound probe manipulation in the rectum (estimated at 0-2 minutes length)

  4. Pain level during periprostatic nerve block

    Self reported by the patient using a 0-10 visual analogue scale. 0 being no pain at all, 10 being worst pain imaginable.

    Time frame: During periprostatic nerve block (rectal wall puncture with needle, estimated at 2-3 minutes after beginning of procedure)

  5. Pain level during biopsy collection

    Self reported by the patient using a 0-10 visual analogue scale. 0 being no pain at all, 10 being worst pain imaginable.

    Time frame: During biopsy collection using an 18-gauge needle (estimated at 3-10 minutes from beginning of procedure)

  6. Pain level at termination of procedure

    Self reported by the patient using a 0-10 visual analogue scale. 0 being no pain at all, 10 being worst pain imaginable.

    Time frame: At termination of procedure (total estimated length of procedure is 10 minutes).

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Lee C, Woo HH. Current methods of analgesia for transrectal ultrasonography (TRUS)-guided prostate biopsy -- a systematic review. BJU Int. 2014 Mar;113 Suppl 2:48-56. doi: 10.1111/bju.12433. PubMed 24053451 ↗
  • Tiong HY, Liew LC, Samuel M, Consigliere D, Esuvaranathan K. A meta-analysis of local anesthesia for transrectal ultrasound-guided biopsy of the prostate. Prostate Cancer Prostatic Dis. 2007;10(2):127-36. doi: 10.1038/sj.pcan.4500935. Epub 2007 Jan 9. PubMed 17211441 ↗
  • Wang J, Wang L, Du Y, He D, Chen X, Li L, Nan X, Fan J. Addition of intrarectal local analgesia to periprostatic nerve block improves pain control for transrectal ultrasonography-guided prostate biopsy: a systematic review and meta-analysis. Int J Urol. 2015 Jan;22(1):62-8. doi: 10.1111/iju.12595. Epub 2014 Aug 21. PubMed 25141759 ↗
  • Raber M, Scattoni V, Roscigno M, Deho F, Briganti A, Salonia A, Gallina A, Di Girolamo V, Montorsi F, Rigatti P. Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial. Eur Urol. 2008 May;53(5):967-73. doi: 10.1016/j.eururo.2007.09.005. Epub 2007 Sep 18. PubMed 17904278 ↗
  • Giannarini G, Autorino R, Valent F, Mogorovich A, Manassero F, De Maria M, Morelli G, Barbone F, Di Lorenzo G, Selli C. Combination of perianal-intrarectal lidocaine-prilocaine cream and periprostatic nerve block for pain control during transrectal ultrasound guided prostate biopsy: a randomized, controlled trial. J Urol. 2009 Feb;181(2):585-91; discussion 591-3. doi: 10.1016/j.juro.2008.10.002. Epub 2008 Dec 13. PubMed 19084860 ↗
  • Barcohana N, Duperon DF, Yashar M. The relationship of application time to EMLA efficacy. J Dent Child (Chic). 2003 Jan-Apr;70(1):51-4. PubMed 12762609 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04064047
Lead sponsor
Assaf-Harofeh Medical Center
Responsible party
Sponsor
First posted
Aug 21, 2019
Start date
Dec 2016
Primary completion
Jul 2017
Completion
Jul 2017
Last update
Jan 13, 2020

Study contacts

Judith Ben Zvi
study chair · Assaf Harofeh Medical Center ethical committee for experiments in humans

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion